Metabolic Advisory Board

A close link with leading researchers is an important asset for exploring novel insights in our core competencies, for applying up-to-date scientific know-how and for staying at the forefront of scientific development.

The metabolic advisory board of 7TM Pharma supports the various development projects and is composed of world-leading experts in the respective therapeutic areas, providing expertise ranging from chemistry and biophysics over biochemistry, molecular pharmacology and signal transduction mechanisms, to in vivo pharmacology and clinical trials. 

 

Prof. Arne V. Astrup

Centre for Advanced Food Studies, The Royal Veterinary & Agricultural University, DK
 

Arne V. Astrup is recognized for his outstanding obesity research. His scientific publications include over 270 original papers and 300 other publications. He is a recipient of many national and international honorary appointments, is member of the Danish National Council for Public Health, Ministry of Health, President-elect of the International Association for the Study of Obesity, and Editor-in-chief of Obesity Reviews, UK. 
 

Prof. John Blundell

Institute of Psychological Sciences, University of Leeds 
 

John Blundell holds the Research Chair of PsychoBiology, is Director of the BioPsychology (Nutrition) Group and Director of the Institute of Psychological Sciences. He has been active in research on mechanisms of appetite control for more than 25 years, the early research covering operation of brain centers. During the 1970s John Blundell was instrumental in establishing a role for the neurotransmitter serotonin in appetite control, including the landmark publication "Is there a role for serotonin (5-hydroxytryptamine) in feeding?" (Blundell JE 1977, International Journal of Obesity, 1: 15-42). His research on the effect of serotonin on human food intake and eating patterns is continuing and involves work on obese patients and anti-obesity drugs.

Prof. Luc Van Gaal 

Dept. Diabetology, Metabolism and Clinical Nutrition, University Hospital Antwerp

Luc F. Van Gaal is an endocrinologist-diabetologist, trained in clinical endocrinology. As head of the Metabolic Unit of the Antwerp University and the Antwerp University hospital, he is one of the leaders in research and care on obesity, the metabolic syndrome and type 2 diabetes. L. Van Gaal has a large expertise in the field of cardiovascular risk factors associated with obesity, as well as extensive experience in the pharmacological approach of obesity and the metabolic syndome. He has authored a large number of publications (more than 250) and is involved in a number of international societies and associations.

Prof. Jens Juul Holst

Medical Physiology, University of Copenhagen, DK
 

Jens Juul Holst has a background in surgery and clinical chemistry and is one of the leaders in research on metabolic regulation, especially his expertise in the field of neuro-endocrine control of pancreatic function is internationally recognized. He made important contributions to the understanding of the role of the incretins in the regulation of insulin secretion. Author of approximately 700 publications, J.J.H. is a recipient of many international awards and member of the Royal Danish Academy of Science and Letters. 
 

Prof. Thue W. Schwartz

Institute for Neuroscience and Pharmacology, University of Copenhagen, DK 
Link to Prof. Thue W. Schwartz CV